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Abstract
The aim of this project is to develop the methodology for the coupling of (pseudo)viologens 
to peptides using solid-phase protocols in order to study, in the future, the supramolecular 
aggregation of the products into controllable β-sheet architectures. It is expected that the 
formation and breaking of those secondary structures can be controlled by the addition of 
cucurbit[8]uril molecules and the variation of the redox and pH conditions. 
For this purpose, in this work two activated (pseudo)viologen derivatives and a model 
peptide have been prepared. The bipyridinium derivatives were prepared following well 
established synthetic methodologies, whilst the β-sheet forming peptide has been generated 
via standard Fmoc solid-phase peptide synthesis protocols. Solid phase couplings between 
the peptide and both (pseudo)viologen derivatives were performed following a Zincke reaction 
between the activated salts and amine moieties placed in two different positions of the peptide 
chain: the N-terminus and the side chain of a Lys residue. 
NMR and HPLC-MS were the techniques used to follow the reactions and to characterize 
the products. Semipreparative HPLC was used as purification method for some of the obtained 
peptide-(pseudo)viologen conjugates. 
Keywords: supramolecular chemistry, solid phase peptide synthesis, viologens, Zincke 
reaction. 
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Resumo 
O obxectivo deste proxecto é desenvolver a metodoloxía para o acoplamento de 
(pseudo)violóxenos a péptidos usando protocolos de fase sólida para estudar, nun futuro, a 
agregación supramolecular dos produtos en forma de estruturas de lámina-β controlables. 
Espérase que a formación e a disociación desas estruturas secundarias pódase controlar coa 
adición de moléculas de cucurbit-[8]-uril e coa variación das condiciones redox e de pH. 
Para este propósito, neste traballo preparáronse dous derivados (pseudo)violóxeno 
activados e un péptido modelo. Os derivados de bipiridinio foron preparados seguido 
metodoloxías sintéticas establecidas, mentres que o péptido que forma de láminas-β foi 
xerado mediante protocolos estándar de síntese de péptidos en fase sólida empregando a 
estratexia Fmoc. Os acoplamentos en fase sólida entre o péptido e ambos derivados 
(pseudo)violóxeno leváronse a cabo seguindo unha reacción de Zincke entre os sales 
activados e as partes amina localizadas en dúas posicións diferentes da cadea peptídica: a 
N-terminal e a cadea lateral dun residuo de Lys. 
As técnicas empregadas para o seguimento das reaccións e para caracterizar os produtos 
foron RMN e HPLC-MS. Empregouse HPLC semipreparativo como método de purificación 
para algúns dos conxugados péptido-(pseudo)violóxeno obtidos. 
Palabras chave: química supramolecular, síntese de péptidos en fase sólida, violóxenos, 
reacción de Zincke. 
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Resumen 
El objetivo de este proyecto es desarrollar la metodología para el acoplamiento de 
(pseudo)viológenos a péptidos usando protocolos de fase sólida para estudiar, en un futuro, 
la agregación supramolecular de los productos en forma de estructuras de lámina-β 
controlables. Se espera que la formación y disociación de estas estructuras secundarias se 
pueda controlar con la adición de moléculas de cucurbit-[8]-uril y con la variación de las 
condiciones redox y de pH. 
Para este propósito, en este trabajo se prepararon dos derivados (pseudo)viológeno 
activados y un péptido modelo. Los derivados de bipiridinio fueron preparados siguiendo 
metodologías sintéticas establecidas, mientras que el péptido que forma de láminas-β fue 
generado mediante protocolos estándar de síntesis de péptidos en fase sólida utilizando la 
estrategia Fmoc. Los acoplamientos en fase sólida entre el péptido y ambos derivados 
(pseudo)viológeno se llevaron a cabo siguiendo una reacción de Zincke entre las sales 
activadas y las partes amina localizadas en dos posiciones diferentes de la cadena peptídica: 
la N-terminal y la cadena lateral de un residuo de Lys. 
Las técnicas empleadas para el seguimiento de las reacciones y para caracterizar los 
productos fueron RMN y HPLC-MS. Se usó HPLC semipreparativo como método de 
purificación para algunos de los conjugados péptido-(pseudo)viológeno obtenidos. 
Palabras clave: química supramolecular, síntesis de péptidos en fase sólida, viológenos, 
reacción de Zincke. 
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Introduction 
Structure and bonding of proteins and peptides 
Peptides and proteins are biopolymers with a wide variety of structures and functions. They 
are formed by monomeric subunits named amino acids. There are 20 standard amino acids, 
which share a common structure, formed by an α-carbon bonded to a hydrogen atom, an 
amine group, a carboxylic group and a R side chain, which distinguishes one amino acid from 
another (Figure 1). Besides, standard amino acids are also called α-amino acids, as the amino 
group is attached at the α-position respect to the carboxylic acid. They also belong to the L 
series, having all of them the same stereochemistry. 
 
Figure 1. Standard amino acid structure. 
R side chains can be completely aliphatic or present different functional groups, and all the 
different amino acids can be named by a three- or one-letter code. Depending on the R side 
chains, the 20 standard natural amino acids can be classified as non-polar (G, A, V, L, I, M, 
F, P, W), polar (S, T, N, Q, Y, C), acid (D, E) or basic (K, R, H).  
 
Table 1. Structure and classification of the 20 natural amino acids, including their one- and three-letter codings.1 
As all amino acids are formed by at least two ionizable groups (amine and carboxylic acid), 
they present two pKas. Some amino acids are defined by an extra pKa, corresponding to an 
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ionizable group present at the side chain. The isoelectric point (pI) is defined as the pH where 
a certain amino acid is found to have net charge equal to zero. 
Amino acids in peptides and proteins are bound to each other through an amide bond, also 
called peptide bond. Successions of multiple amino acids through peptide bonds form the 
primary structure of peptides and proteins. 
 
Figure 2. Planar structure of the peptide bond. 
The Ccarbonyl-N link formed has certain double bond character, due to the resonance of the 
nitrogen with the C-O double bond. Therefore, there is not any free rotation inside the peptide 
bond. On the contrary, both Cα-N and Cα-Ccarbonyl  bonds present free rotation respect to the 
contiguous bond. These two rotations define two angles, ψ and ϕ, which take values between 
-180º and +180º. 
 
Figure 3. Peptide bond rotation.2 
The polypeptidic chains form the primary structure of peptides and proteins, with these 
chains folding to establish the secondary structures defined by angles ψ and ϕ. Secondary 
structures can be classified on the basis of different patterns of hydrogen bonds and other 
intramolecular interactions, including α-helixes, β-sheets, random coils, twists, etc. α-helixes 
and β-sheets were predicted by Linus Pauling and Robert Corey based on H-bonding and 
cooperativity criteria.3,4 
α-helixes present an helicoidal shape (Figure 4), where each turn has 3.6 residues. The 
structure is bound together by H bonds between C=O and NH groups of consecutive turns 
and by Van der Waals interactions. Those H bonds are parallel to the main axis of the helix, 
while the side chains are oriented outwards and perpendicular to the axis. On the other hand, 
β-sheets are defined for having H bonds between different chains (Figure 4), forming plates 
that are not plain, but slightly wrinkled. In the case of β-sheets, H bonds are placed 
perpendicular to the axis of the macromolecule, with the chains being oriented either in a 
parallel or an antiparallel fashion. 
Introduction 
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Figure 4. α-helix (left) and β-sheet (right) structures.2 
Proteins also present tertiary and quaternary structures. The tertiary structure is described 
by the spatial and geometrical distribution of the secondary structure. Due to this distribution, 
new electrostatic, hydrophobic or Van der Waals inter-chain interactions, or H bonds may be 
formed. Therefore, different stable tridimensional conformations are established, forming the 
so-called protein domains, which are usually enough to perform a certain activity by 
themselves. Some proteins are formed by more than one domain, which assemble via non-
covalent interactions leading to the quaternary structure of proteins. 
Solid Phase Peptide Synthesis (SPPS) 
Solid phase peptide synthesis, first developed by Merrifield in 1951,5,6 is the most widely 
method used for the preparation of peptides. SPPS consists in the consecutive addition of 
appropriately modified amino acids to a support polymeric resin. The resin is bound through a 
linker to the so-called C-terminal amino acid, thus the synthetic order of amino acids is from 
the C-terminus to the N-terminus. All amino acids must have their amine groups protected 
when added, so that they attach by forming an amide bond to the last amino acid of the peptide 
chain. Those protective groups are cleaved afterwards, in order to perform the next amino 
acid addition.7 
X
OH
N
R
P X
O
H2N
Rdeprotection coupling
X
OH
N
RO
N
H
P
R'
O
A
H
N
R'
P
P : temporary protective groups
A : active ester  
Scheme 1. General scheme of amino acid coupling in SPPS. 
Functional groups at the side chains must be also protected. In this case, those protective 
groups should not be cleaved until the very end of the peptide synthesis. Therefore, they 
should be resistant to the coupling conditions, but labile to the conditions used for the final 
cleavage of the macromolecule from the resin. 
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Having this in mind, there are two basic SPPS strategies based on orthogonal protective 
groups: Boc/Bz and Fmoc/tBu.8 In the first strategy (Scheme 2), the Boc protective group 
would be used for the α-amino groups, while the Bz group protects the side chain groups. Boc 
can be deprotected by mild acidic conditions (TFA), whilst Bz requires more harsh conditions, 
like HF. 
 
Scheme 2. Boc/Bz strategy scheme. 
In the second strategy (Scheme 3), α-amino groups are protected by Fmoc groups, 
whereas the side chain groups would be protected by the TFA-labile groups such as tBu or 
Trt. Fmoc is easily deprotected with basic media (piperidine). On the other hand, other 
functional groups, as well as the cleavage of the peptide from the resin, require the addition 
of TFA. This method is more convenient than the Boc-based approach, because it avoids the 
use of hazardous HF, and the continuous addition of TFA used in the Boc/Bz strategy can 
also cause problems with some sensitive side chains.9 
H
N
O
OO
O
N
H
Piperidine
TFA
O
 
Scheme 3. Fmoc/tBu strategy scheme. 
The chosen polymeric support plays also a significant role on the SPPS, as the efficiency 
of the couplings depends on the ability of the resin to solvate and swell in an appropriate 
solvent. Most of the coupling reactions occur inside the resin pellets, where all the reagents 
used should have easy access. The linker that joins the resin with the C-terminal amino acid 
is also important. The bond formed must be breakable under the chosen final deprotection 
conditions. The linker also defines the functional group that is eventually obtained at the  
C-terminus. 
In order to perform a coupling and form a peptide bond, it is not enough to add the 
corresponding amino acid to the resin. It is mandatory to activate the carboxylic group of the 
added amino acid using a coupling agent in basic media. There are four main ways of 
performing this activation: carbodiimides, acid anhydrides, activated esters and activated 
esters generated in situ. 
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Carbodiimides like DCC are widely used (Figure 5), with its main drawback being the 
potential dehydration of Asn and Gln residues. However, this issue can be avoided by adding 
HOBt to the reaction mixture. Conversely, anhydrides are usually generated in situ using two 
equivalents of the amino acid, which makes it a less efficient method. 
 
Figure 5. N,N’-Dicyclohexylcarbodiimide (DCC). 
Amino acid derivatives with highly reactive esters are sometimes used. However, it is much 
more common to generate those esters in situ, as it is a simpler method. Activated esters 
suffer degradation when dissolved in the presence of DIEA (the most used base in SPPS). 
Therefore, activation of the amino acids must be performed just before the coupling.10 
 
Figure 6. Common coupling agents used to produce activated esters in situ. 
Viologens in supramolecular chemistry 
Viologens are N,N’-disubstituted derivatives of 4,4’-bipyridine (Figure 7).11 There are 
several methods for the preparation of these organic salts, as the nucleophilic substitution of 
alkyl halides or the Zincke reaction with primary amines. 
 
Figure 7. General structure of viologens and pseudoviologens. 
Due to their rich red/ox chemistry and electronic properties as -deficient aromatic 
molecules, viologens and pseudoviologens (N-monosubstituted 4,4’-bipyridine derivatives) 
have been extensively used on the fields of materials and supramolecular chemistry.12–14 In 
particular, in the context of the work presented herein, it should be considered that, thanks to 
the positive charges placed at both extremes of the (pseudo)viologens units, those can be 
encapsulated as guests via supramolecular interactions inside cucurbituril molecules.  
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Cucurbit[n]urils (CB[n]) are pumpkin-shaped macromolecules formed by the cyclic 
oligomerization of n glycoluril units with formaldehyde (Scheme 4).15 CB[n]s interact with a 
wide variety of inorganic and organic species. In the particular case of organic molecules, 
CB[n]s are capable of acting as hosts and encapsulate them via extremely strong non-covalent 
interactions, forming 1:1 binary complexes. 
 
Scheme 4. Preparation and schematic depictions of cucurbit[n]urils.15 
Positively charged amphiphilic compounds, like viologens, are ideal guests for CB[n]s. 
Positive charges bind through ion-dipole interactions to the carbonylated rims (portal areas) 
of the cucurbituril molecules, whilst the hydrophobic part is placed inside the host’s cavity. 
Therefore, cation-dipole interactions are key interactions for the self-assembly of host and 
guest. Moreover, the hydrophobic effect is also extremely important on those host:guest 
aggregates, as the release of high energy water molecules that are encapsulated inside the 
cucurbituril’s cavity in aqueous solution immensely enhance the binding. 
CB[8], having a cavity of 493 Å3, is the first member of the cucurbituril family capable of 
accepting two appropriate guests (e.g. like monocationic pseudo-viologens), forming in a 
predictable fashion binary 1:1, and homoternary 2:1 complexes based on hydrophobic and 
cation-dipole interactions with appropriate guests (Figure 8). 
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Figure 8. Schematic depictions of  binary and homoternary host:guest complexes between amphiphilic guests 
and cucurbit[8]uril. 
(Pseudo)viologen:CB[8] aggregates are good examples of stimuli-responsive complexes 
(Figure 9). In the case of viologens, the reversible reduction of this type of molecule to a 
radical cation allows the reversible formation of a 2:1 ternary homocomplex. Similarly, the 
CB[8] ternary homocomplex with monocationic pseudoviologens can be reversibly broken by 
diminishing the pH. The acidic conditions protonate pseudoviologens, transforming them into 
dications, which assemble with the CB[8] in the form of 1:1 binary complexes. 
 
Figure 9. Redox and pH-controlled CB[8]:(pseudo)viologen-based supramolecular switches. 
Finally, it should be noted that CB[8] shows a largely negative electrostatic potential inside 
its cavity, with more electron density around the portal areas than smaller cucurbiturils. Due 
to this fact, the hydrophobic and yet polar cavity of the CB[8] is capable of stabilizing 
charge-transfer interactions. Consequently, the inclusion of an electron-donor compound 
(which could not act as guest otherwise) is facilitated, forming a 2:1 heterocomplex with the 
Introduction 
 
13 
 
corresponding electron-acceptor species (Figure 10). The electron-donor/acceptor character 
can be easily modulated for the guests in order to optimize this charge-transfer interaction. 
 
Figure 10. 2:1 heterocomplexes formed by charge transfer interactions within CB[8].16 
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Background 
The synthesis of viologen-peptide conjugates by SPPS has been previously described.17,18 
In that case, the group of Urbach prepared an aminoalkyl viologen and a peptide containing 
Glu residues with orthogonal protecting groups, in  which the viologen unit was attached. After 
the acetylation of the N-terminal amine, Glu side chains were selectively deprotected. 
Subsequently, corresponding carboxylic groups were activated and amide bonds were formed 
between those groups and the amine groups from the aminoalkyl viologens (Scheme 5). 
 
Scheme 5. Viologen-peptide conjugate synthesis using Glu side chains.17 
As previously discussed, viologens have shown the capability of forming 2:1 inclusion 
heterocomplexes within CB[8] with electron-donors.18 Viologens would act as electron 
acceptors, while other molecules such as tryptophan side chains in peptides would act as 
electron donors. 
 
Figure 11. Charge transfer Inclusion heterocomplex between methylviologen and tryptophan.18 
These complexes can be also assembled with both guests, the viologen and the Trp 
residue of a peptide, bound to different scaffolds, allowing the temporary attachment of 
macromolecular building blocks on the basis of host:guest chemistry (Figure 12). 
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Figure 12. Self-assembly of inclusion heterocomplexes attached to scaffolds.18 
The formation of 2:1 homocomplexes containing two viologen units attached to peptides 
has also been reported.19 This complexation occurs under reductive conditions, as the 
viologen molecules must be reduced to radical cations in order to form the 2:1 complex, in 
which the guests place themselves in an antiparallel position. 
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Objective 
In the context of a larger research project, focused on the reversible control of peptide 
aggregation by CB[8]:(pseudo)viologen host:guest chemistry, the main aim of this project is 
the development of viologen-peptide conjugates that would be studied in the future as models 
of -sheet reversible aggregation. 
In this context, the main goals of the present work are: 
1. Synthesis of appropriately-functionalized N-activated (pseudo)viologens 1 and 2, as 
adequate precursors for the synthesis of the peptide-(pseudo)viologen conjugates by 
implementation of the Zincke reaction on the SPPS methodology.  
 
Figure 13. N-activated (pseudo)viologens 1 and 2. 
2. SPPS of the model peptide Fmoc-VQIVYK-NH220, which contains two amino groups, 
one at the Lys (K) side chain and the other at the N-terminus, that can be used for the 
(pseudo)viologen conjugation through solid-phase Zincke reactions.  
 
Figure 14. Model peptide Fmoc-VQIVYK-NH2. 
3. Coupling of the (pseudo)viologen moieties to the peptides through solid-phase Zincke 
reactions. 
Objective 
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Scheme 6. (pseudo)viologen-peptide couplings.
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Results and discussion 
Synthesis of N-activated 4,4’-bipyridinium salts as 
precursors for the Zincke reaction 
As shown on Scheme 7, the designed (pseudo)viologen-peptide conjugates were initially 
planned to be synthesized through Zincke reactions as the key step;21 implemented on the 
last step of standard SPPS protocols.  
 
Scheme 7. Depiction of the solid phase synthesis of the designed peptide-viologen conjugates. 
For this purpose, the first step of the intended work was the synthesis of the N-activated 
4,4’-bipydinium derivatives 1 and 2 (Scheme 8), compounds that would be able to produce 
the desired conjugates through Zincke reactions following an ANROC (Addition of the 
Nucleophile, Ring Opening and Ring Closure) mechanism:22 
 
Scheme 8. ANROC mechanism for the Zincke reaction.22 
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In this context, compound 1 was successfully synthesized in a 83% yield by nucleophilic 
aromatic substitution of 1-chloro-2,4-dinitrobenzene with 4,4’-bipyridine in refluxing EtOH 
(Scheme 9). Following the reported methodology,11,23 after 24 hours, the product was 
precipitated from the reaction mixture with Et2O and washed with AcOEt, rendering the desired 
compound virtually pure, as confirmed by 1H-NMR spectroscopy.  
 
Scheme 9. Synthesis of N-activated pyridinium salts 1 and 2. 
For the synthesis of compound 2, two options were considered. The first one involved the 
activation, by nucleophilic aromatic substitution in refluxing ACN of the already methylated 
derivative 3, which unfortunately did not proceed. Following the second approach, consisting 
in the methylation of compound 1 with excess of MeI in ACN/EtOH at room temperature, 2 
was successfully obtained in a satisfactory yield. 
Peptide design and synthesis 
As discussed before, the main goal of this work is to achieve the synthesis of a 
(pseudo)viologen-modified peptide, which would be used in the future to control β-sheet 
aggregation by means of CB[8]:(pseudo)viologen host:guest chemistry.  
In this context, the peptide Fmoc-VQIVYK-NH2 was chosen both as a well-known β-sheet 
forming peptide sequence,20 and as an appropriate peptide model for the Zincke reactions. 
Those reactions with the (pseudo)viologen precursors 1 and 2 were intended to be performed 
in two amino groups placed at different positions of the peptide chain: the N-terminus and the 
Lys residue side chain. Therefore, to appropriately proceed with the synthesis of the peptide, 
and in order to achieve selectivity for the subsequent Zincke reactions planned to be carried 
out in the final steps of the processes, orthogonal protecting groups must be considered and 
introduced on the structure of the targeted peptide P1/compound 4 (Figure 15). 
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Figure 15. Designed model peptide for its conjugation with (pseudo)viologens. 
Hence, from the chosen sequence (Fmoc-VQIVYK-NH2), Gln (Q), Tyr (Y) and Lys (K) 
residues needed protective groups at their side chains. Gln was protected with Trt and Tyr 
with tBu, both being TFA labile moieties for the final deprotection step. Conversely, with the 
goal of achieving the conjugation of the (pseudo)viologens on the Lys residue side chain, this 
residue was protected with an Alloc group for its subsequent orthogonal deprotection 
regarding to the Fmoc-protected N-terminus (Scheme 10).  
 
Scheme 10. Deprotection mechanism of Fmoc/Alloc containing peptides. 
The designed peptide P1 was successfully synthesized using standard Fmoc solid-phase 
peptide synthesis protocols, consisting on the addition of the corresponding activated 
Fmoc-protected amino acids, removal of the Fmoc protecting group, and repetition of the 
process. Couplings were performed in DMF, which is an appropriate solvent for the swelling 
of the polymeric resin, taking each coupling 30 min to be completed. The synthetic protocol is 
more extensively described at the experimental procedure section. It should be noted that 
peptide P1, when fully protected, had not any easily ionizable groups that allowed its 
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identification by mass spectrometry. Therefore, it was necessary to carry out the deprotection 
of at least one amine group for the identification of the peptide by mass spectrometry. 
(Pseudo)viologen-peptide conjugation 
In order to perform the solid phase Zincke couplings between the Val/Lys-deprotected 
analogues of P1 and compounds 1 and 2, a new SPPS-based methodology had to be 
developed. Therefore, when the coupling is performed at the N-terminus, the deprotection 
step is carried out with piperidine as base, following the SPPS standard protocol. However, 
different conditions must be used when the coupling is done at the Lys side chain, with the 
Alloc protecting group being selectively deprotected with palladium catalysis,24,25 in the 
presence of other acid and base-sensitive protecting groups. The deprotection/coupling steps 
carried out are depicted in the Scheme 11 below: 
 
Scheme 11. General scheme of the (pseudo)viologen-peptide coupling steps. 
The (pseudo)viologen coupling steps were performed in DMF, with compounds 1 or 2 
added as solids and dissolved with the aid of N2 stirring. In contrast to the standard amino acid 
couplings, these Zincke reactions in solid phase take 90 min to be completed. More 
specifically: 
A) Coupling at the Lys side chain. 
The first conjugates were prepared by the coupling of the (pseudo)viologen at the Lys 
residue side chain (Scheme 12). Therefore, the first step was the selective removal of the 
Alloc group with Pd to obtain compound 5. N-methylmorpholine and phenylsilane were the 
nucleophiles chosen for scavenging the allyl groups and regenerating the Pd catalyst. 
 
Scheme 12. (pseudo)viologen-peptide coupling at the Lys side chain. 
Afterwards, two tests of the coupling of 5 with compound 1 were performed, with or without 
the addition of one equivalent of DIEA as base, in order to assure that the amine group of the 
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peptide was not protonated. Both tests gave the same result, as shown on the HPLC traces 
in Figure 16, so the rest of the couplings reported here were performed without base. 
 
Figure 16. HPLC chromatograms of the reaction crude with 1 eq of base (up) and without base (down), in 
which the peak at tR = 14.5 min corresponds to the desired product 6. 
Although three equivalents of compound 1 were used, the reaction was not completed. 
Subsequent attempts with more equivalents of pseudoviologen 1 (6 eq and 10 eq) and re-
couplings did not improve the result. HPLC analysis showed signals corresponding to the 
product (tR = 14.5 min) and the starting material (tR = 15.1 min), as well as other unidentified 
peaks. However, it was noted that those later signals increased respect to the others with the 
amount of compound 1 added. 
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Figure 17. HPLC chromatograms of the reaction crude when adding 3 eq (up), 6 eq (middle) and 10 eq (down) of 
pseudo-viologen 1, in which the peak at tR = 16.3 min corresponds to the desired product 6. 
After MS analysis of the main peaks resolved on the HPLC chromatogram and a thorough 
analysis of the problem at hands, it was found out that the excess of compound 1 (having a 
pyridine moiety on its structure) acted as a base strong enough to remove the Fmoc group. 
HPLC chromatograms showed peaks identified as the desired product (tR = 16.3 min), the 
unreacted peptide (tR = 16.9 min), the product without Fmoc (tR = 10.1 min), and the peptide 
with two pseudoviologens coupled (tR = 10.6 min) (Table 2). 
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Signal m/z Assignation 
A 444.2603 [MH]+; 887.5147 [M]+ Product without Fmoc 
B 513.7815 [M]2+; 1140.5511 [M+TFA]+ Double-coupling product 
C 555.2940 [MH]2+; 1109.5841 [M]+ Product 
D 970.5413 [MH]+ Starting material 
Table 2. Peak analysis of the reaction crude chromatogram for the synthesis of compound 6. 
Coupling between 2 and peptide 5 gave very similar results, with the HPLC chromatograms 
of both couplings being analogous to those obtained for the reactions of 1 and 5 (Table 3). 
This similarity on the chromatograms may be explained on the basis of a demethylation 
process of compound 2 under the coupling conditions used.  
 
Signal m/z Assignation 
A 451.2680 [M] 2+; 1015.5240 [M+TFA]+ Product without Fmoc 
B 641.7903 [M+2TFA]2+; 1397.5712 [M+3TFA]+ Double-coupling product 
C 562.3021 [M]2+; 1237.5917 [M+TFA]+ Product 
D 555.2940 [MH2]2+; 1109.5837 [M]+ Demethylated product 
E 970.5407 [MH]+ Starting material 
Table 3. Peak analysis of the reaction crude chromatogram for the synthesis of compound 7. 
B) Coupling at the Lys side chain on a N-terminal-acetylated peptide 
Because of the above-mentioned problems on the coupling reactions at the side chain of 
the Lys residue, due to the basic (pseudo)viologen reagents being able to remove the Fmoc 
protecting group from the peptide, it was decided to substitute this Fmoc group by an acetyl 
moiety at the N-terminus. In order to do so, the Fmoc group was removed with 
4-methylpiperidine, and the peptide was acetylated with excess of Ac2O. The reaction was 
A 
B 
D C 
A 
B 
C D 
E 
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accomplished without any problem and the acetylated derivative 13 was generated 
(Scheme 13). 
 
Scheme 13. (pseudo)Viologen-peptide coupling at the Lys side chain of the N-acetylated derivative 13. 
Next, in order to proceed with the (pseudo)viologen coupling, the Alloc group at the Lys 
residue side chain was removed as previously described (compound 14), and the coupling 
with 3 equivalents of compound 2 was performed. This time, only one major peak was 
detected on the HPLC chromatogram (tR = 11.4 min) and identified as the desired product 
(compound 15). Other smaller peaks, not absorbing at 280 nm, correspond to side products 
without the viologen chromophore (Figure 18). 
 
Figure 18. HPLC chromatogram of the reaction crude, in which the signal at tR = 11.4 min corresponds to the 
desired product 15. 
The acetylation strategy can be considered an appropriate and efficient way of solving the 
Fmoc-related problem and performing the Zincke coupling at the Lys residue side chain 
without any important side product. 
C) Coupling at the N-terminus. 
For the synthesis of the conjugates at the N-terminus, the Fmoc group had to be removed 
selectively in the presence of the Alloc group protecting the Lys side chain. This was achieved 
by using excess of 4-methylpiperidine, successfully generating compound 8 (Scheme 14). 
FmocHN
4
AllocHN 4
8
N
AllocHN 4
R
9 R = N
10 R = N+-Me
H2N
AllocHN 4
i) 4-methylpiperidine
DMF, 15 min
ii) (pseudo)viologen
DMF, 90 min
 
Scheme 14. (pseudo)viologen-peptide coupling at the N-terminus 8. 
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For the reaction with compound 1, three equivalents of the pseudoviologen were used, with 
the analysis of the product by HPLC giving just one big peak in the chromatogram 
(tR = 12.7 min) corresponding with compound 9, and a small peak corresponding to the 
starting material (tR = 14.5 min) (Figure 19). 
 
Figure 19. HPLC chromatogram of the reaction crude, in which the peak at tR = 12.7 min corresponds to the 
desired product 9. 
This reaction was scaled up from 4.4 µmol to 19.6 µmol, and the same result was obtained. 
For a greater similarity with the -forming peptide described on the bibliography, the Alloc 
group was removed using Pd catalysis, yielding compound 11. The crude was purified by 
reversed-phase semipreparative HPLC, and the collected fractions were lyophilized, obtaining 
a fluffy white solid.  
Coupling of 8 with the activated salt 2 was carried out in the same way as with 1, with three 
equivalents of viologen. Only one significant peak was detected on the HPLC chromatogram 
(tR = 12.3 min), corresponding to the desired conjugate 10 (Figure 20). 
 
Figure 20. HPLC chromatogram of the reaction crude, in which the peak at tR = 12.3 min corresponds to the 
desired product 10. 
This reaction was scaled up as well, from 4.6 µmol to 12.5 µmol. The Alloc group was 
removed with Pd catalysis (giving compound 12), and the crude was purified by reversed-
phase semipreparative HPLC and the collected fractions were lyophilized, obtaining a 
fluffy white solid.  
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Future work 
Several viologen-peptide conjugates have been successfully synthesized by 
implementation of the Zincke reaction in solid phase, and some of them have also been 
purified in an adequate scale. These compounds will be used in the future for controlling the 
-sheet aggregation of the model peptide by reversible CB[8]:(pseudo)viologen host:guest 
chemistry. 
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Experimental procedure 
General information 
All solvents used were synthesis grade, unless specifically noted. Water was purified using 
a Milli-Q system (Millipore). 
All reactions performed for the formation of viologens or pseudo-viologens were followed 
by TLC. Since these compounds are very polar and positively charged, the eluent chosen for 
the chromatography was the mixture formed by ACN (600 mL), MeOH (150 mL), H2O (150 
mL) and NaCl (5 g). The same eluent was used for the compound purification by flash 
chromatography when needed. Products were identified with ultraviolet light at 254 nm and 
360 nm. 
Moreover, all products identities and purities were checked by 1H-NMR spectroscopy, using 
a Bruker Avance 300 (300 MHz) spectrometer. Deuterated water (D2O) and deuterated ACN 
(CD3CN) were the solvents used for the preparation of the samples. 
Reversed-phase HPLC-MS analyses were performed using a Thermo Scientific UltiMate 
3000 connected to a single quadrupole mass spectrometer Thermo Scientific MSQ Plus, and 
a PDA (Photo-Diode Array) detector. HPLC-MS quality solvents were used to prepare the 
eluents, A: 0.1% TFA, H2O and B: 0.1%TFA, ACN. The column used for these analyses was 
Phenomenex Aeris 3.6 µm peptide XB-C18 100 Å; 150 × 2.1 mm. 
The gradient used for reversed-phase HPLC-MS experiments was the following: 
Time (min) Flow (mL/min) % B 
0 0.300 5 
2 0.300 5 
25 0.300 95 
26 0.300 100 
32 0.300 100 
33 0.300 5 
40 0.300 5 
Table 4. Gradient for HPLC and HPLC-MS analysis 
Two semipreparative reversed-phase HPLC purifications were also performed using the 
same instrument without the mass spectrometer. In those cases, the column used was: 
Phenomenex Luna 5 µm C18 100 Å; 250 × 10 mm. 
The amount of solution in each injection was increasingly raised from 5 µL to 100 µL. The 
gradient was also changed, in order to make sure that the peaks were well resolved and that 
the elution time was not too high. The starting gradient was the same showed above, but with 
a flow of 2.500 mL/min. The final gradient (for 100 µL injections) was the following: 
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Time (min) Flow (mL/min) % B 
0 2.500 10 
2 2.500 10 
35 2.500 50 
42 2.500 100 
43 2.500 10 
50 2.500 10 
Table 5. Final gradient for semipreparative HPLC purification 
Purified compounds were lyophilized using a Teslar Cryodos -80 device. 
For a better characterization of the final conjugates MS and reversed-phase HPLC-MS 
analysis were performed with higher resolution instruments and by the staff of the SAI 
(Research Support Facilities) of the UDC. The instruments used were a Bruker Avance 500 
(500 MHz) spectrometer for NMR and a Thermo Scientific Accela connected to a mass 
spectrometer Thermo Scientific LTQ-Orbitrap Discovery for HPLC-MS. 
Synthesis 
N-(2,4-dinitrobenzil)bipyridinium chloride (1) 
 
4,4-bipyridine (12.8 mmol, 1.9973 g) and 1-chloro-2,4-dinitrobenzene (12.8 mmol, 
2.6067 g) were dissolved in EtOH (25 mL), and the mixture was refluxed and stirred for 24 h. 
The reaction was followed by TLC and quenched by air-cooling. The product was precipitated 
(yellowish) by adding Et2O (185 mL aprox.). The precipitate was washed with AcOEt, dissolved 
in MeOH, and concentrated to dryness to give a brown solid (3.7932 g, 82.6 %). 
1H-NMR (300 MHz, D2O) δ: 8.08 (d, 2H, J = 5.8 Hz), 8.30 (d, 1H, J = 8.7 Hz), 8.72 (d, 2H, 
J = 6.5 Hz), 8.88 (d, 2H, J = 5.4 Hz), 8.97 (dd, 1H, J1 = 2.5 Hz, J2 = 8.6 Hz), 9.28 (d, 2H,  
J = 6.4Hz), 9.43 (d, 1H, J = 2.5 Hz). 
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N-(2,4-dinitrobenzene)-N’-methylbipyridinium chloroiodide (2) 
 
Approximately 3-4 mL of EtOH were added over a mixture of compound 1 (0.697 mmol, 
250.9 mg) and ACN (15 mL), until the solid was completely dissolved. Then, MeI (13.94 mmol, 
0.870 mL) was added, and the resulting solution was stirred at rt until the following day. The 
reaction was checked by TLC and it was found to be not completed. Therefore, another portion 
of MeI (13.94 mmol, 0.870 mL) was added and the solution was left again until the following 
day. A precipitate was formed and the mixture turned red. The mixture was vacuum filtered 
and the precipitate was washed with ether. 184.5 mg of a reddish-orange solid were obtained 
(184.5 mg, 52.9 %). 
1H-NMR (300 MHz, D2O) δ: 4.58 (s, 3H), 8.34 (d, 1H, J = 8.7 Hz), 8.68 (d, 2H, J = 6.4 Hz), 
8.87 (d, 2H, J = 6.7 Hz), 9.00 (dd, 1H, J1 = 2.5 Hz, J2 = 8.7 Hz), 9.17 (d, 2H, J = 6.5 Hz), 9.46 
(m, 3H). 
 
N-methylbipyridinium chloride (3) 
 
Compound 1 (1.4 mmol, 0.5039 g) was dissolved in EtOH (20 mL). Then, methylamine 
(3.5 mmol, 300 µL, 40 %) was added and the solution turned immediately black. The resulting 
mixture was stirred at rt for 1 h and followed by TLC. The solution was concentrated to dryness 
and the product was extracted with H2O (40 mL) and AcOEt (40 mL). The aqueous phase was 
washed with AcOEt (100 mL) and concentrated to dryness. 
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Change of counterion: The product was dissolved in the minimum amount of H2O and KPF6 
(3.4 mmol, 0.630 g) was added to the solution. The mixture was stirred, and the precipitated 
salt was filtered, washed with H2O (25 mL), dissolved in ACN, and concentrated to dryness to 
give a pale brown solid (140 mg, 33 %). 
1H-NMR (300 MHz, D2O) δ: 4.43 (s, 3H), 7.91 (d, 2H, J = 5.3 Hz), 8.38 (d, 2H, J = 6.2 Hz), 
8.77 (d, 2H, J = 5.2 Hz), 8.89 (d, 2H, J = 6.5 Hz). 
 
Peptide synthesis (4) 
 
- Resin: H-Rink amide ChemMatrix® resin (0.47 mmol/g) 
- Coupling agent: HBTU/HOBt 0.2 M 
- Base: DIEA 0.195 M 
- TNBS test for the protection/deprotection of the amine group: 1 % TNBS/DMF + 10% 
DIEA/DMF 
- Fmoc deprotecting agent: 4-methylpiperidine 
- Sequence: Val-Gln-Ile-Val-Tyr-Lys (Fmoc-VQIVYK-NH2) 
The resin (0.1 mmol, 216.6 mg) was placed in a plastic column and washed 3 times with DMF 
with N2 bubbling (Figure 21). The amine group was checked to be deprotected with the TNBS 
test (positive result). The protected amino acid Fmoc-Lys(Alloc)-OH (in excess, 4 eq) was 
dissolved in the coupling agent solution (4 eq, 2 mL) and then the DIEA solution (6 eq, 3 mL) 
was added. After 2 min of activation, the resulting solution was added to the resin and mixed 
by N2 bubbling for 30 min. After solvent removal by filtration (figure XB), the resin was washed 
with DMF (2 × 5 mL), and then the Fmoc protecting group was removed by treatment with an 
excess of 4-methylpiperidine (5 mL) during 15 min. The resin was washed three times with 
DMF, and then a TNBS test showed a positive result. This procedure was repeated for each 
amino acid of the peptide sequence (from the C-terminus to the N-terminus). 
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Figure 21. Assembly for SPPS. 
 
Coupling at the Lys side chain 
- Deprotection of the Alloc group: 
FmocHN
Pd(OAc)2, PPh3
NMN, PhSiH3
CH2Cl2, rt, overnight
4
HN
O O
4
FmocHN
5
H2N 4
 
The resin (0.05 mmol) was treated with a mixture of Pd(OAc)2 (0.015 mmol, 3.4 mg), PPh3 
(0.075 mmol, 19.7 mg), PhSiH3 (0.5 mmol, 62 µL) and NMM (0.5 mmol, 55 µL) in CH2Cl2 
(2.5 mL) and the resulting mixture was stirred mechanically until the following day. The resin 
was then filtered and washed with: CH2Cl2 (2 × 2.5 mL × 5 min), DMF (2 × 2.5 mL × 5 min), 
DEDTC (25 mg/5 mL DMF × 15 min), DMF (2 × 2.5 mL × 5 min), and CH2Cl2 (2 × 2.5 mL × 5 
min). 
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- Coupling with compound 1: 
 
A small amount of the resin (4.4 µmol, 15.0 mg) was resuspended in DMF (320 µL) and 
compound 1 (13.2 µmol, 4.8 mg) was added to the mixture. The resin instantly turned black 
and the mixture was mechanically stirred for 90 min. After filtration, the resin was washed DMF 
(2 × 0.5 mL × 5 min) and with CH2Cl2 (2 × 0.5 mL × 5 min). 
3-4 mg of the resin were treated with 150 µL of the cleaving cocktail (2.5% 
triisopropylsilane, TIS, 2.5% H2O and 95% TFA) for 90 min. The resin was then filtered, the 
TFA filtrate was added to ice-cold ether (1.2 mL) and the precipitate centrifugated for 10 min. 
The solid residue was dissolved in 400 µL of H2O and analyzed by reversed-phase HPLC-MS. 
tR = 16.3 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]+ calc. for C61H77N10O10+ = 1109.6, found = 1109.6 [M]+; 555.3 [MH]2+. 
- Coupling with compound 2: 
 
A small amount of the resin (4.4 µmol, 15.0 mg) was resuspended in DMF (320 µL) and 
compound 2 (13.2 µmol, 6.6 mg) was added to the mixture. The resin instantly turned brown-
black and the mixture was mechanically stirred for 90 min. After filtration, the resin was washed 
DMF (2 × 0.5 mL × 5 min) and with CH2Cl2 (2 × 0.5 mL × 5 min). 
3-4 mg of the resin were treated with 150 µL of the cleaving cocktail (2.5% 
triisopropylsilane, TIS, 2.5% H2O and 95% TFA) for 90 min. The resin was then filtered, the 
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TFA filtrate was added to ice-cold ether (1.2 mL) and the precipitate centrifugated for 10 min. 
The solid residue was dissolved in 400 µL of H2O and analyzed by reversed-phase HPLC-MS. 
tR = 16.1 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]2+ calc. for C62H80N10O102+ = 562.3, found = 562.3 [M]2+; 1237.6 [M+TFA]+. 
 
Coupling at the N-terminus 
- Deprotection: 
 
The resin (0.05 mmol) was treated with a solution of 20% 4-methylpiperidine in DMF (2.5 
mL) with N2 bubbling for 15 min, and then was filter and washed with DMF (3 × 2.5 mL × 
5 min). A TNBS test was performed, giving a positive result. The resin was washed with CH2Cl2 
(2 × 2.5 mL × 5 min) and dried under nitrogen. 
- Coupling with compound 1: 
 
A small amount of the resin (4.6 µmol, 15.0 mg) was resuspended in DMF (320 µL) and 
compound 1 (13.2 µmol, 4.7 mg) was added to the mixture. The resin instantly turned black 
and the mixture was mechanically stirred for 90 min. After filtration, the resin was washed DMF 
(2 × 0.5 mL × 5 min) and with CH2Cl2 (2 × 0.5 mL × 5 min). 
3-4 mg of the resin were treated with 150 µL of the cleaving cocktail (2.5% 
triisopropylsilane, TIS, 2.5% H2O and 95% TFA) for 90 min. The resin was then filtered, the 
TFA filtrate was added to ice-cold ether (1.2 mL) and the precipitate centrifugated for 10 min. 
The solid residue was dissolved in 400 µL of H2O and analyzed by reversed-phase HPLC-MS. 
tR = 12.6 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]+ calc. for C50H71N10O10+ = 971.5, found = 971.5 [M]+; 486.3 [MH]2+. 
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- Deprotection of the Alloc group: 
 
The resin (19.6 µmol) was treated with a mixture of Pd(OAc)2 (5.64 µmol, 1.3 mg), PPh3 
(28.2 µmol, 7.4 mg), PhSiH3 (0.188 mmol, 23 µL) and NMM (0.188 mmol, 21 µL) in CH2Cl2 
(1.5 mL) and the resulting mixture was stirred mechanically until the following day. The resin 
was then filtered and washed with: CH2Cl2 (2 × 2.5 mL × 5 min), DMF (2 × 2.5 mL × 5 min), 
DEDTC (25 mg/5 mL DMF × 15 min), DMF (2 × 2.5 mL × 5 min), and CH2Cl2 (2 × 2.5 mL × 
5 min). 
The resin was treated with 3 mL of the cleaving cocktail (2.5% triisopropylsilane, TIS, 2.5% 
H2O and 95% TFA) for approximately 4 h. The resin was then filtered, the TFA filtrate was 
added to ice-cold ether (30 mL) and the precipitate centrifugated at 4 ºC for 15 min. The solid 
residue was dissolved in 1 mL of ACN:H2O (1:1), filtered and purified by semipreparative 
reversed-phase HPLC. 
tR = 10.6 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]+ calc. for C46H67N10O8+ = 887.5, found = 887.5 [M]+; 444.3 [MH]2+. 
- Coupling with compound 2: 
 
A small amount of the resin (4.6 µmol, 15.0 mg) was resuspended in DMF (320 µL) and 
compound 2 (13.8 µmol, 6.9 mg) was added to the mixture. The resin instantly turned brown-
black and the mixture was mechanically stirred for 90 min. After filtration, the resin was washed 
DMF (2 × 0.5 mL × 5 min) and with CH2Cl2 (2 × 0.5 mL × 5 min). 
3-4 mg of the resin were treated with 150 µL of the cleaving cocktail (2.5% 
triisopropylsilane, TIS, 2.5% H2O and 95% TFA) for 90 min. The resin was then filtered, the 
TFA filtrate was added to ice-cold ether (1.2 mL) and the precipitate centrifugated for 10 min. 
The solid residue was dissolved in 400 µL of H2O and analyzed by reversed-phase HPLC-MS. 
tR = 12.3 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]2+ calc. for C51H74N10O102+ = 493.3, found = 493.3 [M]2+; 1099.6 [M+TFA]+. 
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- Deprotection of the Alloc group: 
 
The resin (12.5 µmol) was treated with a mixture of Pd(OAc)2 (3.75 µmol, 0.8 mg), PPh3 
(18.8 µmol, 4.9 mg), PhSiH3 (0.125 mmol, 16 µL) and NMM (0.125 mmol, 14 µL) in CH2Cl2 
(1.5 mL) and the resulting mixture was stirred mechanically until the following day. The resin 
was then filtered and washed with: CH2Cl2 (2 × 2.5 mL × 5 min), DMF (2 × 2.5 mL × 5 min), 
DEDTC (25 mg/5 mL DMF × 15 min), DMF (2 × 2.5 mL × 5 min), and CH2Cl2 (2 × 2.5 mL × 
5 min). 
The resin was treated with 2 mL of the cleaving cocktail (2.5% triisopropylsilane, TIS, 2.5% 
H2O and 95% TFA) for approximately 2.5 h. The resin was then filtered, the TFA filtrate was 
added to ice-cold ether (20 mL) and the precipitate centrifugated at 4 ºC for 15 min. The solid 
residue was dissolved in 1 mL of ACN:H2O (1:1), filtered and purified by semipreparative 
reversed-phase HPLC. 
tR = 10.3 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]2+ calc. for C47H70N10O82+ = 451.3, found = 451.3 [M]2+; 1015.5 [M+TFA]+. 
 
Coupling to the Lys side chain of the N-terminus acetylated peptide 
- Acetylation: 
 
Ac2O (0.146 mmol, 14 µL) and DIEA (0.175 mmol, 900 µL, 0.195 M in DMF) were mixed 
and added to the resin (14.6 µmol, 47.6 mg). The mixture was stirred by N2 bubbling for 15 min, 
and then was filter and washed with DMF (3 × 2.5 mL × 5 min). A TNBS test was performed, 
giving a negative result. 
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- Deprotection of the Alloc group: 
 
The resin (14.6 µmol) was treated with a mixture of Pd(OAc)2 (4.38 µmol, 1.0 mg), PPh3 
(4.4 µmol, 5.7 mg), PhSiH3 (0.146 mmol, 18 µL) and NMM (0.146 mmol, 16 µL) in CH2Cl2 
(1.5 mL) and the resulting mixture was stirred mechanically until the following day. The resin 
was then filtered and washed with: CH2Cl2 (2 × 2.5 mL × 5 min), DMF (2 × 2.5 mL × 5 min), 
DEDTC (25 mg/5 mL DMF × 15 min), DMF (2 × 2.5 mL × 5 min), and CH2Cl2 (2 × 2.5 mL × 
5 min). 
- Coupling with compound 2: 
 
The resin (14.6 µmol) was resuspended in DMF (2.5 mL) and compound 2 (43.8 µmol, 
21.9 mg) was added to the mixture. The resin instantly turned dark maroon and the mixture 
was mechanically stirred for 90 min. After filtration, the resin was washed DMF (2 × 0.5 mL × 
5 min) and with CH2Cl2 (2 × 0.5 mL × 5 min) and dried under nitrogen. 
3-4 mg of the resin were treated with 150 µL of the cleaving cocktail (2.5% 
triisopropylsilane, TIS, 2.5% H2O and 95% TFA) for 90 min. The resin was then filtered, the 
TFA filtrate was added to ice-cold ether (1.2 mL) and the precipitate centrifugated for 10 min. 
The solid residue was dissolved in 400 µL of H2O and analyzed by reversed-phase HPLC-MS. 
tR = 11.4 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z): [M]2+ calc. for C49H72N10O92+ = 472.3, found = 472.3 [M]2+; 1057.6 [M+TFA]+.
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Conclusions 
Regarding the work done in this project, the following conclusions can be stated: 
 Two (pseudo)viologens derivatives were successfully prepared: N-(2,4-
dinitrobenzil)bipyridinium chloride (compound 1) and N-(2,4-dinitrobenzil)-N’-
methylbipyridinium chloroiodide (compound 2) as appropriate precursors for Zincke 
reactions. 
 A model β-sheet-forming peptide was synthesized via standard Fmoc solid-
phase peptide synthesis protocols: Fmoc-VQIVYK-NH2. According to the bibliography, 
this peptide forms -sheet secondary structures in aqueous solutions. 
 A new SPPS-based protocol has been developed for the coupling, via Zincke 
reactions, of (pseudo)viologen moieties to an amine group placed in two different 
positions of the model peptide: the N-terminus and the side chain of the Lys residue. 
 Couplings at the N-terminus of the Val residue worked properly, whereas 
couplings at the Lys side chain were found more problematic, due to the deprotection 
of the Fmoc protective group under the mild basic conditions produced by the 
(pseudo)viologen reagents. Conversion of the Fmoc protecting group into a more 
base-resistant acetyl group was found a good strategy for the coupling of the 
(pseudo)viologen units at the Lys side chain, resulting in the desired conjugates 
without side products. 
 The series of (pseudo)viologen-peptide conjugates prepared will be used in the 
future for the reversible host:guest-controlled -sheet aggregation of the peptides.
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Conclusións 
Considerando o traballo realizado neste proxecto, pódense enunciar as seguintes 
conclusións: 
 Preparáronse con éxito dous derivados (pseudo)violóxenos:  cloruro de N-(2,4-
dinitrobenzil)bipiridinio (composto 1) e cloroioduro de N-(2,4-dinitrobenzil)-N’-
metilbipiridinio (composto 2) como precursores apropiados para reaccións de Zincke. 
 Sintetizouse un péptido modelo que forma láminas-β: Fmoc-VQIVYK-NH2, 
usando protocolos de síntese de péptidos en fase sólida e seguindo a estratexia Fmoc. 
De acordo coa bibliografía, dito péptido forma estruturas secundarias de lámina-β en 
disolucións acuosas. 
 Desenvolveuse un novo protocolo baseado na SPPS para o acoplamento, 
mediante reaccións de Zincke, de fragmentos (pseudo)violóxeno cos grupos amina de 
dúas posicións diferentes do péptido modelo: a N-terminal e a cadea lateral do residuo 
de Lys. 
 Os acoplamentos no N-terminal do residuo de Val funcionaron 
adecuadamente, mentres que os acoplamentos na cadea lateral da Lys atopáronse 
máis problemáticos, debido á desprotección do grupo protector Fmoc baixo as 
condicións lixeiramente básicas producidas polos reactivos (pseudo)violóxenos. A 
sustitución do grupo protector Fmoc por un grupo acetilo, que é máis resistente a 
medios básicos, resulta ser unha boa estratexia para o acoplamento de unidades de 
(pseudo)violóxeno á cadea lateral da Lys, dando como resultado os conxugados 
desexados sen produtos secundarios. 
Os conxugados (pseudo)violóxeno-péptido preparados serán empregados nun futuro na 
agregación reversible de péptidos en láminas-β controlada por fenómenos receptor:hóspede.
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Conclusiones 
Considerando el trabajo realizado en este proyecto, se pueden enunciar las siguientes 
conclusiones: 
 Se prepararon con éxito dos derivados (pseudo)viológenos: cloruro de N-(2,4-
dinitrobenzil)bipiridinio (compuesto 1) y cloroyoduro de N-(2,4-dinitrobenzil)-N’-
metilbipiridinio (compuesto 2) como precursores apropiados para reacciones de 
Zincke. 
 Se sintetizó un péptido modelo que forma láminas-β: Fmoc-VQIVYK-NH2, 
usando protocolos de síntesis de péptidos en fase sólida y siguiendo la estrategia 
Fmoc. De acuerdo con la bibliografía, dicho péptido forma estructuras secundarias de 
lámina-β en disoluciones acuosas. 
 Se desarrolló un nuevo protocolo basado en la SPPS para el acoplamiento, 
mediante reacciones de Zincke, de fragmentos (pseudo)viológeno con los grupos 
amina de diferentes posiciones del péptido modelo: la N-terminal y la cadena lateral 
del residuo de Lys. 
 Los acoplamientos en el N-terminal del residuo de Val funcionaron 
adecuadamente, mientras que los acoplamientos en la cadena lateral de la Lys se 
encontraron más problemáticos, debido a la desprotección del grupo protector Fmoc 
bajo las condiciones ligeramente básicas producidas por los reactivos 
(pseudo)viológenos. La sustitución del grupo protector Fmoc por un grupo acetilo, que 
es más resistente a medios básicos, resulta ser una buena estrategia para el 
acoplamiento de unidades de (pseudo)viológeno a la cadena lateral de la Lys, dando 
como resultado los conjugados deseados sin productos secundarios. 
 Los conjugados (pseudo)viológeno-péptido preparados serán empleados en 
un futuro en la agregación reversible de péptidos en láminas-β controlada por 
fenómenos receptor:huésped.
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Compound 1 
 
1H-NMR spectrum (300 MHz, D2O) for compound 1. 
Compound 2 
 
1H-NMR spectrum (300 MHz, D2O) for compound 2. 
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II 
 
Compound 3 
 
1H-NMR spectrum (300 MHz, D2O) for compound 3. 
Compound 10 
 
HPLC chromatogram of compound 10. 
Annex 
 
III 
 
 
ESI-MS spectrum of the HPLC chromatogram peak at 11.6 min corresponding to compound 10. 
Compound 12 
 
HPLC chromatogram of compound 12. 
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IV 
 
 
ESI-MS spectrum of the HPLC chromatogram peak at 10.3 min corresponding to compound 12. 
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